Related Experiment Video
Updated: Oct 10, 2026
Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E
Published on: September 26, 2019
Ulcerative colitis, but not Crohn's disease, displays demographically and clinically driven mucosal immune
Ángel De Prado1, Irene Soleto2, Carolina G de Castro1
1Mucosal Immunology Lab, Institute of Biomedicine and Molecular Genetics from Valladolid (IBGM Universidad de Valladolid-CSIC), Valladolid, Spain.
Background:
Inflammatory bowel disease (IBD) encompasses Crohn's disease (CD) and ulcerative colitis (UC), two conditions with distinct immunopathological profiles despite shared inflammatory pathways. Comparative mucosal and systemic immune characterisation across disease subtypes and clinical variables remains limited. This study aimed to map leukocyte dysregulation in tissue and blood from patients with CD and UC compared to controls.
Methods:
Intestinal tissue and blood samples were obtained from 35 controls and endoscopically active IBD patients, including 54 with CD and 74 with UC. Leukocyte subsets were identified using a 29-marker spectral cytometry panel combining hierarchical gating with unsupervised clustering and dimensionality reduction. Immune composition was stratified by disease location, biological sex, age and endoscopic severity.
Results:
Hierarchical gating identified 41 mucosal and 42 circulating immune subsets; unsupervised clustering resolved 51 mucosal and 62 blood clusters. Both diseases displayed dysregulated mucosal immunity relative to controls but with distinct signatures: while CD was mainly T-cell biased, UC showed a mixed infiltrate with an increased relative proportion of NK, NKT and IgG+ B-cells. UC also exhibited substantially greater immunological heterogeneity than CD when stratified by biological sex, age and severity, with effects predominantly confined to the mucosa. Ileal and colonic CD showed minor immunological differences.
Conclusions:
UC displayed more prominent subgroup-associated mucosal immune heterogeneity than CD, particularly according to biological sex, age and endoscopic severity. These findings support tissue-resolved patient stratification in UC and highlight the limited sensitivity of blood-based biomarkers to reflect mucosal immune alterations.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:26Inflammatory Bowel Disease I: Introduction
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...